| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |